article · International Immunopharmacology

Experimental verification of Myriocin molecular bioactivity in revoking rheumatoid arthritis: New emphasis on S100A1 repression and PPAR-γ activation via non-canonical pathways in the flare-up of cytokines

Ghada S. El‐Tanbouly

20252 citationsDelta University for Science and Technology

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

S100 Proteins and Annexins
Immune Response and Inflammation
Cytokine Signaling Pathways and Interactions

Sustainable Development Goals

2Zero Hunger

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.intimp.2025.114811

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.